Tunisian start-up MajestEYE is selected by JICA, the Japanese International Cooperation Agency, among the top 10 most innovative start-ups in Africa in the framework of the international innovation competition NINJA (Next INnovation with JApan).
JICA selected MajestEYE for its Artificial Intelligence solution DrugEYE, which sets to disrupt the Drug Discovery & repurposing process.
MajestEYE introduced DrugEYE earlier this year demonstrating astonishing speed, accuracy and precision in analyzing SARS-CoV-2 and is now a scalable solution that enables pharmaceutical companies and research laboratories to analyse any microbial-organism in record times and in a fully data driven way.
JICA selected DrugEYE among 2, 700 submitted projects. MajestEYE is the only Tunisian and North African Laureate of the NINJA competition.
Jihed Hannachi, Co-founder of MajestEYE, will present DrugEYE next February 26 to 3, 000 Japanese company representatives in an event organized by JICA and NIKKEI.
Jihed Hannachi declares “after its introduction to the German Market, DrugEYE continues its International saga with an introduction to the Japanese market in collaboration with JICA.
We are honored to represent Tunisian and African innovation internationally. MajestEYE made a strategic choice for innovation and autonomy by developing our own Artificial Intelligence technology.”
DrugEYE being featured internationally is a consequence of that strategic choice. We are both proud and determined to continue on our chosen path.”
